News for Intercept Pharma Stock (ICPT)

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ICPT

PRNewsWire • 01/03/21

FINAL DEADLINE MONDAY: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Monday Deadline in Securities Class Action - ICPT

Newsfile Corp • 01/02/21

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Intercept Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Business Wire • 01/02/21

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. (ICPT)

Business Wire • 12/30/20

The 10 Worst Performing Stocks of 2020

The Motley Fool • 12/29/20

Rosen, A Longstanding and Trusted Firm, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action - ICPT

Newsfile Corp • 12/29/20

SHAREHOLDER ALERT: ICPT BIIB KNDI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire • 12/28/20

JAN 4 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Intercept Pharmaceuticals, Inc.– ICPT

GlobeNewsWire • 12/28/20

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Intercept Pharmaceuticals, Inc. and Certain Officers - ICPT

Newsfile Corp • 12/26/20

CLASS ACTION UPDATE for ICPT, TILE and BABA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire • 12/24/20

ROSEN, A TOP RANKED LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action – ICPT

GlobeNewsWire • 12/24/20

ICPT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 4, 2021 in the Class Action Filed on Behalf of Intercept Pharmaceuticals, Inc. Limited Shareholders

Newsfile Corp • 12/24/20

ICPT DEADLINE: Zhang Investor Law Reminds Investors with Losses of the Deadline in Securities Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. – ICPT

GlobeNewsWire • 12/23/20

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of RTX, ICPT and HPQ

Accesswire • 12/22/20

ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - ICPT

PRNewsWire • 12/22/20

Intercept Pharmaceuticals, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit - Portnoy Law Firm

GlobeNewsWire • 12/22/20

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. (ICPT)

GlobeNewsWire • 12/21/20

Rosen, Top Ranked Investor Counsel, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - ICPT

Newsfile Corp • 12/15/20

ICPT INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Filed Against Intercept Pharmaceuticals, Inc.

GlobeNewsWire • 12/15/20

Pomerantz Law Firm Announces the Filing of a Class Action against Intercept Pharmaceuticals, Inc. and Certain Officers – ICPT

GlobeNewsWire • 12/13/20

ICPT INVESTOR DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Filed Against Intercept Pharmaceuticals, Inc.

PRNewsWire • 12/10/20

Intercept Pharmaceuticals Announces Leadership Transition

GlobeNewsWire • 12/10/20

Rosen, Top Ranked National Investor Attorneys, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action - ICPT

Newsfile Corp • 12/09/20

Intercept (ICPT) Down 14.4% Since Last Earnings Report: Can It Rebound?

Zacks Investment Research • 12/09/20

SHAREHOLDER DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Intercept Pharmaceuticals, Inc.– ICPT

GlobeNewsWire • 12/09/20